These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28703441)

  • 1. Discovery of Small Molecules that Induce the Degradation of Huntingtin.
    Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M
    Angew Chem Int Ed Engl; 2017 Sep; 56(38):11530-11533. PubMed ID: 28703441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
    Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
    Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative.
    Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2018 Feb; 28(4):707-710. PubMed ID: 29366651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
    Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrodin Improves the Activity of the Ubiquitin-Proteasome System and the Autophagy-Lysosome Pathway to Degrade Mutant Huntingtin.
    Sun H; Li M; Li Y; Zheng N; Li J; Li X; Liu Y; Ji Q; Zhou L; Su J; Huang W; Liu Z; Liu P; Zou L
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
    Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L
    Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
    Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
    Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
    Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
    Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.
    Liu Y; Hettinger CL; Zhang D; Rezvani K; Wang X; Wang H
    J Neurochem; 2014 May; 129(3):539-47. PubMed ID: 24383989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A toxic mutant huntingtin species is resistant to selective autophagy.
    Fu Y; Wu P; Pan Y; Sun X; Yang H; Difiglia M; Lu B
    Nat Chem Biol; 2017 Nov; 13(11):1152-1154. PubMed ID: 28869595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.
    Bertoglio D; Bard J; Hessmann M; Liu L; Gärtner A; De Lombaerde S; Huscher B; Zajicek F; Miranda A; Peters F; Herrmann F; Schaertl S; Vasilkovska T; Brown CJ; Johnson PD; Prime ME; Mills MR; Van der Linden A; Mrzljak L; Khetarpal V; Wang Y; Marchionini DM; Skinbjerg M; Verhaeghe J; Dominguez C; Staelens S; Munoz-Sanjuan I
    Sci Transl Med; 2022 Feb; 14(630):eabm3682. PubMed ID: 35108063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease.
    Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H
    Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological control of mitochondria as the novel mechanism of Gastrodia elata in attenuating mutant huntingtin-induced protein aggregations.
    Huang NK; Lin CC; Lin YL; Huang CL; Chiou CT; Lee YC; Lee SY; Huang HT; Yang YC
    Phytomedicine; 2019 Jun; 59():152756. PubMed ID: 31004885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible Inhibitor Based on Chitosan and Amphiphilic Peptide against Mutant Huntingtin Toxicity.
    Wahyuningtyas D; Chen WH; Huang CH; He YJ; Huang JJ
    Chembiochem; 2019 Aug; 20(16):2133-2140. PubMed ID: 31166067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the proteostasis network in Huntington's disease.
    Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
    Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine-Specific Gold Nanoparticle Complex Alleviates Mutant Huntingtin-Induced Toxicity.
    Wahyuningtyas D; Chen WH; He RY; Huang YA; Tsao CK; He YJ; Yu CY; Lu PC; Chen YC; Wang SH; Ng KC; Po-Wen Chen B; Wei PK; Shie JJ; Kuo CH; Sun YH; Jen-Tse Huang J
    ACS Appl Mater Interfaces; 2021 Dec; 13(51):60894-60906. PubMed ID: 34914364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.
    Zhao T; Hong Y; Li S; Li XJ
    J Neurosci; 2016 Aug; 36(32):8317-28. PubMed ID: 27511006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of toxicity of the mutant huntingtin protein by its interacting compound, desonide.
    Song H; Wang C; Zhu C; Wang Z; Yang H; Wu P; Cui X; Botas J; Dang Y; Ding Y; Fei Y; Lu B
    Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2114303119. PubMed ID: 35238684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.